156 related articles for article (PubMed ID: 24700752)
21. Intraprocedural 3D Quantification of Lipiodol Deposition on Cone-Beam CT Predicts Tumor Response After Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma.
Wang Z; Chen R; Duran R; Zhao Y; Yenokyan G; Chapiro J; Schernthaner R; Radaelli A; Lin M; Geschwind JF
Cardiovasc Intervent Radiol; 2015 Dec; 38(6):1548-56. PubMed ID: 26001366
[TBL] [Abstract][Full Text] [Related]
22. Stable polyanhydride synthesized from sebacic acid and ricinoleic acid.
Haim-Zada M; Basu A; Hagigit T; Schlinger R; Grishko M; Kraminsky A; Hanuka E; Domb AJ
J Control Release; 2017 Jul; 257():156-162. PubMed ID: 27126904
[TBL] [Abstract][Full Text] [Related]
23. Feasibility of poly (ϵ-caprolactone-co-DL-lactide) as a biodegradable material for in situ forming implants: evaluation of drug release and in vivo degradation.
Zhang X; Zhang C; Zhang W; Meng S; Liu D; Wang P; Guo J; Li J; Guan Y; Yang D
Drug Dev Ind Pharm; 2015 Feb; 41(2):342-52. PubMed ID: 24320881
[TBL] [Abstract][Full Text] [Related]
24. Holmium-lipiodol-alginate microspheres for fluoroscopy-guided embolotherapy and multimodality imaging.
Oerlemans C; Seevinck PR; Smits ML; Hennink WE; Bakker CJ; van den Bosch MA; Nijsen JF
Int J Pharm; 2015 Mar; 482(1-2):47-53. PubMed ID: 25448561
[TBL] [Abstract][Full Text] [Related]
25. Chemical shift MR imaging methods for the quantification of transcatheter lipiodol delivery to the liver: preclinical feasibility studies in a rodent model.
Yin X; Guo Y; Li W; Huo E; Zhang Z; Nicolai J; Kleps RA; Hernando D; Katsaggelos AK; Omary RA; Larson AC
Radiology; 2012 Jun; 263(3):714-22. PubMed ID: 22623693
[TBL] [Abstract][Full Text] [Related]
26. Research of novel biocompatible radiopaque microcapsules for arterial embolization.
Lu XJ; Zhang Y; Cui DC; Meng WJ; Du LR; Guan HT; Zheng ZZ; Fu NQ; Lv TS; Song L; Zou YH; Lu WL; Fan TY
Int J Pharm; 2013 Aug; 452(1-2):211-9. PubMed ID: 23707965
[TBL] [Abstract][Full Text] [Related]
27. Localization of pulmonary nodules with lipiodol prior to thoracoscopic surgery.
Kim YD; Jeong YJ; I H; Cho JS; Lee JW; Kim HJ; Lee SH; Kim DH
Acta Radiol; 2011 Feb; 52(1):64-9. PubMed ID: 21498328
[TBL] [Abstract][Full Text] [Related]
28. Ricinoleic acid-based biopolymers.
Teomim D; Nyska A; Domb AJ
J Biomed Mater Res; 1999 Jun; 45(3):258-67. PubMed ID: 10397984
[TBL] [Abstract][Full Text] [Related]
29. A study of image-guided radiotherapy of bladder cancer based on lipiodol injection in the bladder wall.
Søndergaard J; Olsen KØ; Muren LP; Elstrøm UV; Grau C; Høyer M
Acta Oncol; 2010 Oct; 49(7):1109-15. PubMed ID: 20429726
[TBL] [Abstract][Full Text] [Related]
30. Biodegradable poly(polyol sebacate) polymers.
Bruggeman JP; de Bruin BJ; Bettinger CJ; Langer R
Biomaterials; 2008 Dec; 29(36):4726-35. PubMed ID: 18824260
[TBL] [Abstract][Full Text] [Related]
31. Interstitial taxol delivered from a biodegradable polymer implant against experimental malignant glioma.
Walter KA; Cahan MA; Gur A; Tyler B; Hilton J; Colvin OM; Burger PC; Domb A; Brem H
Cancer Res; 1994 Apr; 54(8):2207-12. PubMed ID: 7909720
[TBL] [Abstract][Full Text] [Related]
32. Optimal measurement modality and method for evaluation of responses to transarterial chemoembolization of hepatocellular carcinoma based on enhancement criteria.
Shim JH; Han S; Shin YM; Yu E; Park W; Kim KM; Lim YS; Lee HC
J Vasc Interv Radiol; 2013 Mar; 24(3):316-25. PubMed ID: 23312990
[TBL] [Abstract][Full Text] [Related]
33. Biodegradable polymer-mediated intratumoral delivery of cisplatin for treatment of human head and neck squamous cell carcinoma in a chimeric mouse model.
Chen FA; Kuriakose MA; Zhou MX; DeLacure MD; Dunn RL
Head Neck; 2003 Jul; 25(7):554-60. PubMed ID: 12808659
[TBL] [Abstract][Full Text] [Related]
34. A tough biodegradable elastomer.
Wang Y; Ameer GA; Sheppard BJ; Langer R
Nat Biotechnol; 2002 Jun; 20(6):602-6. PubMed ID: 12042865
[TBL] [Abstract][Full Text] [Related]
35. Metabolic disposition and elimination studies of a radiolabelled biodegradable polymeric implant in the rat brain.
Domb AJ; Rock M; Schwartz J; Perkin C; Yipchuk G; Broxup B; Villemure JG
Biomaterials; 1994 Jul; 15(9):681-8. PubMed ID: 7948590
[TBL] [Abstract][Full Text] [Related]
36. [The magnetic resonance of small hepatocarcinoma. A comparison with echography, computed tomography, digital angiography and computed tomography with lipiodol].
De Santis M; Cristani A; Cioni G; Casolo A; Canossi G; Ventura E; Romagnoli R
Radiol Med; 1992 Nov; 84(5):587-95. PubMed ID: 1335589
[TBL] [Abstract][Full Text] [Related]
37. Noninvasive monitoring of local drug release using X-ray computed tomography: optimization and in vitro/in vivo validation.
Szymanski-Exner A; Stowe NT; Salem K; Lazebnik R; Haaga JR; Wilson DL; Gao J
J Pharm Sci; 2003 Feb; 92(2):289-96. PubMed ID: 12532379
[TBL] [Abstract][Full Text] [Related]
38. Correlation between tumor perfusion and lipiodol deposition in hepatocellular carcinoma after transarterial chemoembolization.
Yang L; Zhang XM; Zhou XP; Tang W; Guan YS; Zhai ZH; Dong GL
J Vasc Interv Radiol; 2010 Dec; 21(12):1841-6. PubMed ID: 20980165
[TBL] [Abstract][Full Text] [Related]
39. In vivo versus in vitro degradation of controlled release polymers for intracranial surgical therapy.
Wu MP; Tamada JA; Brem H; Langer R
J Biomed Mater Res; 1994 Mar; 28(3):387-95. PubMed ID: 8077254
[TBL] [Abstract][Full Text] [Related]
40. Development of biodegradable in situ implant and microparticle injectable formulations for sustained delivery of haloperidol.
Ahmed TA; Ibrahim HM; Ibrahim F; Samy AM; Kaseem A; Nutan MT; Hussain MD
J Pharm Sci; 2012 Oct; 101(10):3753-62. PubMed ID: 22753324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
